{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:09:26Z","timestamp":1761505766165,"version":"build-2065373602"},"reference-count":47,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lung-cancer.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lung Cancer"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/j.cllc.2016.08.007","type":"journal-article","created":{"date-parts":[[2016,11,9]],"date-time":"2016-11-09T07:04:45Z","timestamp":1478675085000},"page":"178-188.e4","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Correlation of DNA Repair Gene Polymorphisms With Clinical Outcome in Patients With Locally Advanced Non\u2013Small-Cell Lung Cancer Receiving Induction Chemotherapy Followed by Surgery"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1942-2134","authenticated-orcid":false,"given":"Mariacarmela","family":"Santarpia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Luis","family":"Ramirez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Itziar","family":"de Aguirre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pilar","family":"Garrido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"P\u00e9rez Cano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Queralt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose Luis","family":"Gonzalez-Larriba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amelia","family":"Insa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariano","family":"Provencio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dolores","family":"Isla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Camps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Remei","family":"Blanco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Moran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Rosell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cllc.2016.08.007_bib1","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature12213","article-title":"Mutational heterogeneity in cancer and the search for new cancer-associated genes","volume":"499","author":"Lawrence","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.cllc.2016.08.007_bib2","series-title":"Molecular-Based Decision Making for Personalized Cancer Management","first-page":"136","article-title":"Lung Adenocarcinoma","author":"Rosell","year":"2012"},{"key":"10.1016\/j.cllc.2016.08.007_bib3","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrm3822","article-title":"Understanding nucleotide excision repair and its roles in cancer and ageing","volume":"15","author":"Marteijn","year":"2014","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.cllc.2016.08.007_bib4","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1093\/jnci\/94.14.1091","article-title":"An analysis of DNA repair as a determinant of survival in patients with non-small-cell lung cancer","volume":"94","author":"Bosken","year":"2002","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.cllc.2016.08.007_bib5","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1093\/carcin\/21.11.1977","article-title":"Identification of single nucleotide polymorphisms in human DNA repair genes","volume":"21","author":"Ford","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.cllc.2016.08.007_bib6","first-page":"1354","article-title":"Modulation of nucleotide excision repair capacity by XPD polymorphisms in lung cancer patients","volume":"61","author":"Spitz","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.cllc.2016.08.007_bib7","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/carcin\/bgi232","article-title":"Polymorphisms of DNA repair genes and risk of non-small cell lung cancer","volume":"27","author":"Zienolddiny","year":"2006","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.cllc.2016.08.007_bib8","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1093\/aje\/kwj189","article-title":"XRCC3 and XPD\/ERCC2 single nucleotide polymorphisms and the risk of cancer: a HuGE review","volume":"164","author":"Manuguerra","year":"2006","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.cllc.2016.08.007_bib9","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1097\/FPC.0b013e3280115e63","article-title":"Single nucleotide polymorphisms of the DNA repair gene XPD\/ERCC2 alter mRNA expression","volume":"17","author":"Wolfe","year":"2007","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/j.cllc.2016.08.007_bib10","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1097\/JTO.0b013e3181e7fe2a","article-title":"ERCC2\/XPD Lys751Gln and Asp312Asn gene polymorphism and lung cancer risk: a meta-analysis involving 22 case-control studies","volume":"5","author":"Zhan","year":"2010","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2016.08.007_bib11","first-page":"5457","article-title":"Regulation of cisplatin resistance and homologous recombinational repair by the TFIIH subunit XPD","volume":"62","author":"Aloyz","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.cllc.2016.08.007_bib12","first-page":"7430","article-title":"Functional significance of XPD polymorphic variants: attenuated apoptosis in human lymphoblastoid cells with the XPD 312 Asp\/Asp genotype","volume":"61","author":"Seker","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.cllc.2016.08.007_bib13","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1093\/carcin\/21.4.551","article-title":"XPD polymorphisms: effects on DNA repair proficiency","volume":"21","author":"Lunn","year":"2000","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.cllc.2016.08.007_bib14","first-page":"604","article-title":"Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans","volume":"58","author":"Shen","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.cllc.2016.08.007_bib15","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1093\/carcin\/22.4.593","article-title":"Genetic polymorphisms in DNA repair genes and risk of lung cancer","volume":"22","author":"Butkiewicz","year":"2001","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.cllc.2016.08.007_bib16","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0962-8924(03)00171-5","article-title":"RecQ helicases: multiple roles in genome maintenance","volume":"13","author":"Khakhar","year":"2003","journal-title":"Trends Cell Biol"},{"key":"10.1016\/j.cllc.2016.08.007_bib17","first-page":"8654","article-title":"A\u00a0Xeroderma pigmentosum group D gene polymorphism predicts clinical outcome to platinum-based chemotherapy in patients with advanced colorectal cancer","volume":"61","author":"Park","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.cllc.2016.08.007_bib18","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/annonc\/mdh319","article-title":"Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer","volume":"15","author":"Isla","year":"2004","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cllc.2016.08.007_bib19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.lungcan.2010.05.005","article-title":"Single nucleotide polymorphisms in MDR1 gen correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbine","volume":"71","author":"Vi\u00f1olas","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2016.08.007_bib20","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00280-012-1985-9","article-title":"Prospective assessment of XRCC3, XPD and Aurora kinase A single-nucleotide polymorphisms in advanced lung cancer","volume":"70","author":"Provencio","year":"2012","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/j.cllc.2016.08.007_bib21","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/annonc\/mdj135","article-title":"Polymorphisms in DNA repair genes modulate survival in cisplatin\/gemcitabine-treated non-small-cell lung cancer patients","volume":"17","author":"de las Pe\u00f1as","year":"2006","journal-title":"Ann Oncol"},{"key":"10.1016\/j.cllc.2016.08.007_bib22","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1200\/JCO.2004.08.067","article-title":"XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy","volume":"22","author":"Gurubhagavatula","year":"2004","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2016.08.007_bib23","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1002\/cncr.21885","article-title":"Xeroderma pigmentosum group D haplotype predicts for response, survival, and toxicity after platinum-based chemotherapy in advanced nonsmall cell lung cancer","volume":"106","author":"Booton","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.cllc.2016.08.007_bib24","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1097\/JTO.0b013e3182307e1f","article-title":"Association of cytidine deaminase and xeroderma pigmentosum group D polymorphisms with response, toxicity, and survival in cisplatin\/gemcitabine-treated advanced non-small cell lung cancer patients","volume":"6","author":"Ludovini","year":"2011","journal-title":"J\u00a0Thorac Oncol"},{"key":"10.1016\/j.cllc.2016.08.007_bib25","doi-asserted-by":"crossref","first-page":"228","DOI":"10.4238\/2014.January.14.2","article-title":"Pharmacogenetics of DNA repair gene polymorphisms in non-small-cell lung carcinoma patients on platinum-based chemotherapy","volume":"13","author":"Zhang","year":"2014","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.cllc.2016.08.007_bib26","doi-asserted-by":"crossref","first-page":"3310","DOI":"10.4238\/2014.April.29.9","article-title":"Association of xeroderma pigmentosum group D (Asp312Asn, Lys751Gln) and cytidine deaminase (Lys27Gln, Ala70Thr) polymorphisms with outcome in Chinese non-small cell lung cancer patients treated with cisplatin-gemcitabine","volume":"13","author":"Zhou","year":"2014","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.cllc.2016.08.007_bib27","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1007\/s003359901114","article-title":"Lung cancer and the human gene for ribonucleotide reductase subunit M1 (RRM1)","volume":"10","author":"Pitterle","year":"1999","journal-title":"Mamm Genome"},{"key":"10.1016\/j.cllc.2016.08.007_bib28","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.lungcan.2004.07.043","article-title":"Ribonucleotide reductase M1 gene promoter activity, polymorphisms, population frequencies, and clinical relevance","volume":"47","author":"Bepler","year":"2005","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2016.08.007_bib29","doi-asserted-by":"crossref","first-page":"3761","DOI":"10.1158\/0008-5472.CAN-03-3363","article-title":"An increase in the expression of ribonucleotide reductase large subunit 1 is associated with gemcitabine resistance in non-small cell lung cancer cell lines","volume":"64","author":"Davidson","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.cllc.2016.08.007_bib30","doi-asserted-by":"crossref","first-page":"4731","DOI":"10.1200\/JCO.2006.06.1101","article-title":"RRM1 modulated in\u00a0vitro and in\u00a0vivo efficacy of gemcitabine and platinum in non-small cell lung cancer","volume":"24","author":"Bepler","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2016.08.007_bib31","doi-asserted-by":"crossref","first-page":"3548","DOI":"10.1038\/sj.onc.1206419","article-title":"Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer","volume":"22","author":"Rosell","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.cllc.2016.08.007_bib32","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1158\/1078-0432.CCR-03-0156","article-title":"Ribonucleotide reductase messenger RNA expression and survival in gemcitabine\/cisplatin-treated advanced non-small cell lung cancer patients","volume":"10","author":"Rosell","year":"2004","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.cllc.2016.08.007_bib33","doi-asserted-by":"crossref","first-page":"4736","DOI":"10.1200\/JCO.2007.12.0014","article-title":"Long-term survival associated with complete resection after induction chemotherapy in stage IIIA (N2) and IIIB (T4N0-1) non small-cell lung cancer patients: the Spanish Lung Cancer Group Trial 9901","volume":"25","author":"Garrido","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2016.08.007_bib34","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.canlet.2005.12.026","article-title":"The XPD Asp312Asn and Lys751Gln polymorphisms, corresponding haplotype, and pancreatic cancer risk","volume":"245","author":"Jiao","year":"2007","journal-title":"Cancer Lett"},{"key":"10.1016\/j.cllc.2016.08.007_bib35","doi-asserted-by":"crossref","first-page":"e72251","DOI":"10.1371\/journal.pone.0072251","article-title":"Predictive value of XPD polymorphisms on platinum-based chemotherapy in non-small cell lung cancer: a systematic review and meta-analysis","volume":"8","author":"Qiu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cllc.2016.08.007_bib36","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s12032-010-9443-1","article-title":"Predictive value of ERCC1 and XPD polymorphism in patients with advanced non-small cell lung cancer receiving platinum-based chemotherapy: a systematic review and meta-analysis","volume":"28","author":"Wei","year":"2011","journal-title":"Med Oncol"},{"key":"10.1016\/j.cllc.2016.08.007_bib37","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.lungcan.2010.10.011","article-title":"No evidence of an association of ERCC1 and ERCC2 polymorphisms with clinical outcomes of platinum-based chemotherapies in non-small cell lung cancer: a meta-analysis","volume":"72","author":"Yin","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2016.08.007_bib38","doi-asserted-by":"crossref","first-page":"e79864","DOI":"10.1371\/journal.pone.0079864","article-title":"Polymorphisms in XPD gene could predict clinical outcome of platinum-based chemotherapy for non-small cell lung cancer patients: a meta-analysis of 24 studies","volume":"8","author":"Qin","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.cllc.2016.08.007_bib39","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.lungcan.2010.11.004","article-title":"Assessment of XPD Lys751Gln and XRCC1 T-77C polymorphisms in advanced non-small-cell lung cancer patients treated with platinum-based chemotherapy","volume":"73","author":"Liu","year":"2011","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2016.08.007_bib40","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.lungcan.2011.05.023","article-title":"Association between polymorphisms of DNA repair genes and survival of advanced NSCLC patients treated with platinum-based chemotherapy","volume":"75","author":"Ren","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.cllc.2016.08.007_bib41","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1038\/bjc.2013.127","article-title":"ERCC1\/BRCA1 expression and gene polymorphisms as prognostic and predictive factors in advanced NSCLC treated with or without cisplatin","volume":"108","author":"Tiseo","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/j.cllc.2016.08.007_bib42","doi-asserted-by":"crossref","first-page":"e99843","DOI":"10.1371\/journal.pone.0099843","article-title":"Associations of polymorphisms in DNA repair genes and MDR1 gene with chemotherapy response and survival of non-small cell lung cancer","volume":"9","author":"Du","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.cllc.2016.08.007_bib43","first-page":"12","article-title":"Conformational effects of a common codon 751 polymorphism on the C-terminal domain of the xeroderma pigmentosum D protein","volume":"8","author":"Monaco","year":"2009","journal-title":"J\u00a0Carcinog"},{"key":"10.1016\/j.cllc.2016.08.007_bib44","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1200\/JCO.2006.09.7915","article-title":"Customizing cisplatin based on quantitative excision repair cross-complementing 1 mRNA expression: a phase III trial in non-small-cell lung cancer","volume":"25","author":"Cobo","year":"2007","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2016.08.007_bib45","doi-asserted-by":"crossref","first-page":"e5133","DOI":"10.1371\/journal.pone.0005133","article-title":"Customized treatment in non-small-cell lung cancer based on EGFR mutations and BRCA1 mRNA expression","volume":"4","author":"Rosell","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.cllc.2016.08.007_bib46","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1200\/JCO.2012.43.0900","article-title":"ERCC1 and RRM1: ready for prime time?","volume":"31","author":"Besse","year":"2013","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.cllc.2016.08.007_bib47","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1093\/annonc\/mdu389","article-title":"Two biomarker-directed randomized trials in European and Chinese patients with non-small-cell lung cancer: the BRCA1-RAP80 Expression Customization (BREC) studies","volume":"25","author":"Moran","year":"2014","journal-title":"Ann Oncol"}],"container-title":["Clinical Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152573041630242X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152573041630242X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T19:06:31Z","timestamp":1761505591000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152573041630242X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":47,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S152573041630242X"],"URL":"https:\/\/doi.org\/10.1016\/j.cllc.2016.08.007","relation":{},"ISSN":["1525-7304"],"issn-type":[{"type":"print","value":"1525-7304"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correlation of DNA Repair Gene Polymorphisms With Clinical Outcome in Patients With Locally Advanced Non\u2013Small-Cell Lung Cancer Receiving Induction Chemotherapy Followed by Surgery","name":"articletitle","label":"Article Title"},{"value":"Clinical Lung Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cllc.2016.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}